APOTHEEK SPYSSCHAERT
De berekende faillissementskans van APOTHEEK SPYSSCHAERT over 12 maanden bedraagt 0,5% (laag). Het bedrijf is actief sinds 1989 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 36 jaar |
| Vestigingen | 1 |
| Publicaties | 1 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | verkort | 02-06-2026 | 2026-00132445 |
| 31-12-2024 | verkort | 17-07-2025 | 2025-00285851 |
| 31-12-2023 | verkort | 09-07-2024 | 2024-00227285 |
| 31-12-2022 | verkort | 28-08-2023 | 2023-00361020 |
| 31-12-2021 | verkort | 28-09-2022 | 2022-20438393 |
| 31-12-2020 | verkort | 12-10-2021 | 2021-71700098 |
| 31-12-2019 | verkort | 08-09-2020 | 2020-51400469 |
| 31-12-2018 | verkort | 18-07-2019 | 2019-34000016 |
| 31-12-2017 | verkort | 27-08-2018 | 2018-49700125 |
| 31-12-2016 | verkort | 17-07-2017 | 2017-31300338 |
| NACE primair | Detailhandel(47730) |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 08-12-1989 |
| Status | Actief |
| Postcode | 2390 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 11032B0187/00D002 | Vlaanderen | 927 m² | - | - |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
31-01-2025 Kapitaalverhoging van €1.132.368,30
- 3 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 1132368.3,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 750,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 745.47
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "gewone",
"n_new_shares": 1519,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inkoop_eigen_aandelen",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": null,
"delta_eur": -750.0,
"before_eur": null,
"decrease_purpose": "share_cancellation",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": 750,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": 6200.0,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": 6200.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 2269,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Davien GEUNS",
"firm_city": null,
"firm_name": "Notariaat Noma",
"office_city": "Malle",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-31",
"filing_date": "2025-01-22",
"act_kind_objet": "BUITENGEWONE ALGEMENE VERGADERING: FUSIE DOOR OVERNEMING OVEREENKOMSTIG DE ARTIKELEN 12:2 JUNCTO 12:24 EN VOLGENDE VAN HET WETBOEK VAN VENNOOTSCHAPPEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-01-15",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": "0434.036.891",
"firm_name": "VAN HAVERMAET BEDRIJFSREVISOREN",
"ibr_number": null,
"mission_type": "inbreng_in_natura",
"individual_name": "Amerik JANSEN"
},
"subject_company": {
"kbo": "0439.190.363",
"name_full": "A\u0420\u041E\u0422\u041D\u0415\u0415K SPYSSCHAERT",
"legal_form": "besloten vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Afschrift akte",
"Verslag van het bestuursorgaan cfr. artikel 5:133, \u00A71 juncto artikel 5:121, \u00A71 WVV",
"Verslag van het bestuursorgaan cfr. artikel 5:101 WVV",
"Controleverslag van de bedrijfsrevisor cfr. artikel 5:133, \u00A71 juncto artikel 5:121, \u00A71 WVV",
"Geco\u00F6rdineerde statuten (bewaard in de Databank van Statuten)"
],
"shareholders_after": [],
"share_classes_after": []
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | APOTHEEK SPYSSCHAERT |